Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M McLaughlin

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|January 25, 2019
Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United StatesJohn M McLaughlin, David L Swerdlow, Farid Khan, et al.
JAMA|September 15, 2023
Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 YearsSara Y Tartof, Timothy B Frankland, Jeff M Slezak, et al.
Open Forum Infectious Diseases|July 17, 2024
Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 SublineagesSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Expert Review of Vaccines|November 30, 2017
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of ageRaul E Isturiz, Cassandra Hall-Murray, John M McLaughlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2020
County-level Predictors of Coronavirus Disease 2019 (COVID-19) Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?John M McLaughlin, Farid Khan, Sarah Pugh, et al.
Scientific Reports|March 8, 2023
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and EuropeTimothy L Wiemken, Farid Khan, Laura Puzniak, et al.
Nature Communications|November 3, 2024
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare SystemAisling R Caffrey, Haley J Appaneal, Vrishali V Lopes, et al.
JAMA Network Open|March 18, 2022
Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate VaccineAmber Hsiao, John Hansen, Julius Timbol, et al.
The Journal of Infectious Diseases|November 5, 2023
Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail PharmacyAbby E Rudolph, Farid L Khan, Amy Shah, et al.
RNA Biology|September 23, 2016
The temporally controlled expression of Drongo, the fruit fly homolog of AGFG1, is achieved in female germline cells via P-bodies and its localization requires functional Rab11Irina E Catrina, Livia V Bayer, Giussepe Yanez, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|January 25, 2019
Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United StatesJohn M McLaughlin, David L Swerdlow, Farid Khan, et al.
JAMA|September 15, 2023
Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 YearsSara Y Tartof, Timothy B Frankland, Jeff M Slezak, et al.
Open Forum Infectious Diseases|July 17, 2024
Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 SublineagesSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Expert Review of Vaccines|November 30, 2017
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of ageRaul E Isturiz, Cassandra Hall-Murray, John M McLaughlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2020
County-level Predictors of Coronavirus Disease 2019 (COVID-19) Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?John M McLaughlin, Farid Khan, Sarah Pugh, et al.
Scientific Reports|March 8, 2023
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and EuropeTimothy L Wiemken, Farid Khan, Laura Puzniak, et al.
Nature Communications|November 3, 2024
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare SystemAisling R Caffrey, Haley J Appaneal, Vrishali V Lopes, et al.
JAMA Network Open|March 18, 2022
Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate VaccineAmber Hsiao, John Hansen, Julius Timbol, et al.
The Journal of Infectious Diseases|November 5, 2023
Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail PharmacyAbby E Rudolph, Farid L Khan, Amy Shah, et al.
RNA Biology|September 23, 2016
The temporally controlled expression of Drongo, the fruit fly homolog of AGFG1, is achieved in female germline cells via P-bodies and its localization requires functional Rab11Irina E Catrina, Livia V Bayer, Giussepe Yanez, et al.
Pageof 10